Bartlett & Co Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bartlett & Co Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68K	Hold	574	–	–	﹤0.01%	686
2026 Q1	$60.8K	Hold	574	–	–	﹤0.01%	648
2025 Q4	$60K	Hold	574	–	–	﹤0.01%	633
2025 Q3	$53.1K	Hold	574	–	–	﹤0.01%	661
2025 Q2	$45.8K	Hold	574	–	–	﹤0.01%	667
2025 Q1	$49.7K	Hold	574	–	–	﹤0.01%	650
2024 Q4	$47.4K	Hold	574	–	–	﹤0.01%	660
2024 Q3	$49.9K	Hold	574	–	–	﹤0.01%	657
2024 Q2	$47.2K	Hold	574	–	–	﹤0.01%	669
2024 Q1	$46K	Hold	574	–	–	﹤0.01%	678
2023 Q4	$43.8K	Hold	574	–	–	﹤0.01%	732
2023 Q3	$41.5K	Hold	574	–	–	﹤0.01%	691
2023 Q2	$43.4K	Hold	574	–	–	﹤0.01%	695
2023 Q1	$43.6K	Hold	574	–	–	﹤0.01%	590
2022 Q4	$45.1K	Hold	574	–	–	﹤0.01%	596
2022 Q3	$40.9K	Hold	574	–	–	﹤0.01%	594
2022 Q2	$43K	Hold	574	–	–	﹤0.01%	593
2022 Q1	$45.7K	Buy	+574	New	+$44.5K	﹤0.01%	593
2021 Q4	–	Sell	-624	Closed	-$48.3K	–	748
2021 Q3	$48.3K	Buy	624 +50	+9%	+$4.03K	﹤0.01%	514
2021 Q2	$46.2K	Hold	574	–	–	﹤0.01%	523
2021 Q1	$45.3K	Hold	574	–	–	﹤0.01%	556
2020 Q4	$41K	Hold	574	–	–	﹤0.01%	561
2020 Q3	$36.7K	Hold	574	–	–	﹤0.01%	533
2020 Q2	$37.1K	Hold	574	–	–	﹤0.01%	537
2020 Q1	$31.6K	Hold	574	–	–	﹤0.01%	531
2019 Q4	$37.1K	Hold	574	–	–	﹤0.01%	576
2019 Q3	$32.5K	Hold	574	–	–	﹤0.01%	595
2019 Q2	$34.5K	Hold	574	–	–	﹤0.01%	481
2019 Q1	$37.4K	Hold	574	–	–	﹤0.01%	459
2018 Q4	$35.8K	Hold	574	–	–	﹤0.01%	455
2018 Q3	$42.2K	Hold	574	–	–	﹤0.01%	456
2018 Q2	$38.6K	Hold	574	–	–	﹤0.01%	451
2018 Q1	$35.8K	Buy	+574	New	+$37.8K	﹤0.01%	461

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Bartlett & Co Wealth Management's PJP Position: Q2 2026 in Review

Bartlett & Co Wealth Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 574 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Bartlett & Co Wealth Management first reported a position in PJP in Q1 2018 and has held it in 33 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Bartlett & Co Wealth Management held 574 shares of Invesco Pharmaceuticals ETF worth $68K as of Q2 2026.
Bartlett & Co Wealth Management left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #686 holding.
Bartlett & Co Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2018 and has held it in 33 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.